Simon H. Stertzer, Director at BioCardia, Inc. (BCDA), bought 1,000 shares at $2.45 ($2K) on 2025-03-05, disclosed to the SEC on 2025-03-07.
Open-market purchase of $2k BCDA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| BCDA | BUY | 2025-07-02 | $301K | — | Filing → |
| BCDA | BUY | 2025-04-25 | $401K | — | Filing → |
| BCDA | BUY | 2025-03-05 | $140K | — | Filing → |